Robert J. Straka

The Clinical Pharmacogenetics Implementation Consortium Guideline for <i>SLCO1B1</i>, <i>ABCG2</i>, and <i>CYP2C9</i> genotypes and Statin‐Associated Musculoskeletal Symptoms

Rhonda M. Cooper‐DeHoff, Mikko Niemi, Laura B. Ramsey et al. · Clinical Pharmacology & Therapeutics · 2022 · 331 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Metabolomic profiling of 17 bile acids in serum from patients with primary biliary cirrhosis and primary sclerosing cholangitis: A pilot study

Jocelyn Trottier, Andrzej Białek, Patrick Caron et al. · Digestive and Liver Disease · 2011 · 155 citations

Life Sciences, Biochemistry, Hepatology +13

Patient Self‐Reporting of Compliance Does Not Correspond with Electronic Monitoring: An Evaluation Using Isosorbide Dinitrate as a Model Drug

Robert J. Straka, Jeffrey Fish, Steven R. Benson et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 1997 · 134 citations · Full text

Pharmacy, Cardiology, Pharmacology +17

The −256T&amp;gt;C Polymorphism in the Apolipoprotein A-II Gene Promoter Is Associated with Body Mass Index and Food Intake in the Genetics of Lipid Lowering Drugs and Diet Network Study

Dolores Corella, Donna K. Arnett, Michael Y. Tsai et al. · Clinical Chemistry · 2007 · 122 citations

Life Sciences, Genetics, Molecular Genetics +10

Fenofibrate Effect on Triglyceride and Postprandial Response of Apolipoprotein A5 Variants

Chao‐Qiang Lai, Donna K. Arnett, Dolores Corella et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2007 · 118 citations

Medicine, Endocrinology, Pharmacology +14